Mitochondria-targeted carrier-free nanoparticles based on dihydroartemisinin against hepatocellular carcinoma
aJoint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People’s Republic of China, International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510006, China
bGuangzhou Yuemei Pharmaceutical Technology Co., Ltd., Guangzhou 510535, China
cAffiliated Foshan Maternity & Child Healthcare Hospital, Southern Medical University, Foshan 528000, China
dSchool of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China
eDepartment of Laboratory Medicine, Dongguan Institute of Clinical Cancer Research, Dongguan Key Laboratory of Precision Diagnosis and Treatment for Tumors, The Tenth Affiliated Hospital of Southern Medical University (Dongguan People’s Hospital), Dongguan 523058, China
收起